TY - JOUR
T1 - Cardiovascular disease risk factors and left ventricular hypertrophy in girls and boys with CKD
AU - Ruebner, Rebecca L.
AU - Ng, Derek
AU - Mitsnefes, Mark
AU - Foster, Bethany J.
AU - Meyers, Kevin
AU - Warady, Bradley
AU - Furth, Susan L.
N1 - Funding Information:
Data in this manuscript were collected by the Chronic Kidney Disease in Children (CKiD) study with clinical coordinating centers (Principal Investigators) at Children’s Mercy Hospital and the University of Missouri, Kansas City (B.W.) and Children’s Hospital of Philadelphia (S.L.F.); central biochemistry laboratory (George Schwartz) at the University of Rochester Medical Center; and data coordinating center (Alvaro Munoz) at the Johns Hopkins Bloom-berg School of Public Health. The CKiD study is funded by the National Institute of Diabetes and Digestive and Kidney Diseases, with additional funding from the National Institute of Child Health and Human Development, and the National Heart, Lung, and Blood Institute (grant nos.: U01-DK-66143, U01-DK-66174, U01-DK-082194, and U01-DK-66116). Funding for this study was also provided by the FOCUS on Health and Leadership for Women Junior Faculty Award for Research in Women’s Cardiovascular Health, funded by the Edna G. Kynett Memorial Foundation.
Publisher Copyright:
© 2016 by the American Society of Nephrology.
PY - 2016
Y1 - 2016
N2 - Background and objectives Prior studies suggested that women with CKD have higher risk for cardiovascular disease (CVD) and mortality than men, although putative mechanisms for this higher risk have not been identified. We assessed sex differences in (1) CVD risk factors and left ventricular hypertrophy (LVH), and (2) the relationship of left ventricular mass (LVM) with different measures of body size in children with CKD. Design, setting, participants, and measurements The study population comprised 681 children with CKD from the Chronic Kidney Disease in Children cohort, contributing 1330 visits. CVD risk factors were compared cross-sectionally by sex. LVH was defined as LVM/height2.7>95th percentile and LVM relative to estimated lean body mass (eLBM)>95th percentile for age and sex. Differences in LVM by sex were assessed by adjusting for age, weight, height, and eLBM using bivariate and multivariate regression models. Results Girls were less likely to have uncontrolled hypertension (26% versus 38%, P=0.001), had lower diastolic BP z-scores (+0.3 versus +0.6, P=0.001), and had lower prevalence of high triglycerides (38% versus 47%, P=0.03) compared with boys. When LVH was defined by LVM indexed to height, girls had higher prevalence of LVH (16% versus 9%, P=0.01); when LVH was defined by LVM relative to eLBM, prevalence of LVH was similar between girls and boys (18% versus 17%, P=0.92). In regression models adjusting for eLBM, no sex differences in LVM were observed. Conclusions Despite lack of increased prevalence of CVD risk factors, indexing LVM to height showed a higher proportion of LVH among girls, while estimates of LVH based on eLBM showed no sex differences. Indexing LVM to eLBM may be an alternative to height indexing in children with CKD.
AB - Background and objectives Prior studies suggested that women with CKD have higher risk for cardiovascular disease (CVD) and mortality than men, although putative mechanisms for this higher risk have not been identified. We assessed sex differences in (1) CVD risk factors and left ventricular hypertrophy (LVH), and (2) the relationship of left ventricular mass (LVM) with different measures of body size in children with CKD. Design, setting, participants, and measurements The study population comprised 681 children with CKD from the Chronic Kidney Disease in Children cohort, contributing 1330 visits. CVD risk factors were compared cross-sectionally by sex. LVH was defined as LVM/height2.7>95th percentile and LVM relative to estimated lean body mass (eLBM)>95th percentile for age and sex. Differences in LVM by sex were assessed by adjusting for age, weight, height, and eLBM using bivariate and multivariate regression models. Results Girls were less likely to have uncontrolled hypertension (26% versus 38%, P=0.001), had lower diastolic BP z-scores (+0.3 versus +0.6, P=0.001), and had lower prevalence of high triglycerides (38% versus 47%, P=0.03) compared with boys. When LVH was defined by LVM indexed to height, girls had higher prevalence of LVH (16% versus 9%, P=0.01); when LVH was defined by LVM relative to eLBM, prevalence of LVH was similar between girls and boys (18% versus 17%, P=0.92). In regression models adjusting for eLBM, no sex differences in LVM were observed. Conclusions Despite lack of increased prevalence of CVD risk factors, indexing LVM to height showed a higher proportion of LVH among girls, while estimates of LVH based on eLBM showed no sex differences. Indexing LVM to eLBM may be an alternative to height indexing in children with CKD.
KW - Body Size
KW - Body Weight
KW - Humans
KW - Hypertrophy, Left Ventricular
KW - Male
KW - Prevalence
KW - Renal Insufficiency, Chronic
KW - Sex Characteristics
KW - Triglycerides
KW - cardiovascular disease
KW - child
KW - chronic kidney disease
KW - female
KW - hypertension
KW - left ventricular hypertrophy
KW - pediatric nephrology
KW - risk factors
UR - http://www.scopus.com/inward/record.url?scp=85021697424&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85021697424&partnerID=8YFLogxK
U2 - 10.2215/CJN.01270216
DO - 10.2215/CJN.01270216
M3 - Article
C2 - 27630183
AN - SCOPUS:85021697424
SN - 1555-9041
VL - 11
SP - 1962
EP - 1968
JO - Clinical journal of the American Society of Nephrology : CJASN
JF - Clinical journal of the American Society of Nephrology : CJASN
IS - 11
ER -